Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Alter

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Scientific Reports|May 24, 2022
Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONETFranziska C Trudzinski, Rudolf A Jörres, Peter Alter, et al.
Scientific Reports|January 27, 2022
Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatmentKathrin Kahnert, Stefan Andreas, Christina Kellerer, et al.
Respiratory Research|January 15, 2017
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohortKathrin Kahnert, Tanja Lucke, Frank Biertz, et al.
Scientific Reports|December 19, 2022
Cardiovascular predictors of mortality and exacerbations in patients with COPDPeter Alter, Tanja Lucke, Henrik Watz, et al.
BMC Pulmonary Medicine|February 29, 2024
Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONETJennifer A Zader, Rudolf A Jörres, Imke Mayer, et al.
Respiration; International Review of Thoracic Diseases|August 20, 2020
Effects of Vibration Training in Interstitial Lung Diseases: A Randomized Controlled TrialAndreas Rembert Koczulla, Tobias Boeselt, Janina Koelpin, et al.
Respiration; International Review of Thoracic Diseases|March 17, 2026
The Montafon proposal: New insights and emerging concepts in pulmonary rehabilitationPeter Alter, Swantje Beyer, Michael J Fischer, et al.
Respiratory Research|September 10, 2021
Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONETChristina Kellerer, Rudolf A Jörres, Antonius Schneider, et al.
Plos One|May 16, 2017
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohortKathrin Kahnert, Tanja Lucke, Rudolf M Huber, et al.
Respiratory Medicine|February 8, 2018
The revised GOLD 2017 COPD categorization in relation to comorbiditiesKathrin Kahnert, Peter Alter, David Young, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Scientific Reports|May 24, 2022
Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONETFranziska C Trudzinski, Rudolf A Jörres, Peter Alter, et al.
Scientific Reports|January 27, 2022
Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatmentKathrin Kahnert, Stefan Andreas, Christina Kellerer, et al.
Respiratory Research|January 15, 2017
Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohortKathrin Kahnert, Tanja Lucke, Frank Biertz, et al.
Scientific Reports|December 19, 2022
Cardiovascular predictors of mortality and exacerbations in patients with COPDPeter Alter, Tanja Lucke, Henrik Watz, et al.
BMC Pulmonary Medicine|February 29, 2024
Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONETJennifer A Zader, Rudolf A Jörres, Imke Mayer, et al.
Respiration; International Review of Thoracic Diseases|August 20, 2020
Effects of Vibration Training in Interstitial Lung Diseases: A Randomized Controlled TrialAndreas Rembert Koczulla, Tobias Boeselt, Janina Koelpin, et al.
Respiration; International Review of Thoracic Diseases|March 17, 2026
The Montafon proposal: New insights and emerging concepts in pulmonary rehabilitationPeter Alter, Swantje Beyer, Michael J Fischer, et al.
Respiratory Research|September 10, 2021
Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONETChristina Kellerer, Rudolf A Jörres, Antonius Schneider, et al.
Plos One|May 16, 2017
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohortKathrin Kahnert, Tanja Lucke, Rudolf M Huber, et al.
Respiratory Medicine|February 8, 2018
The revised GOLD 2017 COPD categorization in relation to comorbiditiesKathrin Kahnert, Peter Alter, David Young, et al.
Pageof 15